Table 1.
Subjects | Benign N = 20 (%) |
Malignant N = 96 (%) |
|
---|---|---|---|
Sex | Female | 20 (100) | 93 (96.88) |
Male | 0 (0) | 3 (3.13) | |
Age Distribution (Years) |
Range | 52–87 | 27–92 |
Age (years) | Mean ± SD | 66 ± 11 | 63 ± 17 |
Smoking | Smokers | 1 (5) | 24 (25) |
Pack Year (PY) ± SD |
40 | 27 ± 19 | |
Alcohol Consumption |
Social or Occasional Drinker | 5 (25) | 28 (29.17) |
Regular Drinker | 0 (0) | 3 (3.13) | |
ER Status | Positive | N/A | 37 (38.58) |
Negative | N/A | 19 (19.79) | |
Unknown | N/A | 6 (6.25) | |
PR Status | Positive | N/A | 31 (32.29) |
Negative | N/A | 30 (31.25) | |
Unknown | N/A | 6 (6.25) | |
HER2 Status | Positive | N/A | 21 (21.88) |
Negative | N/A | 61 (63.54) | |
Unknown | N/A | 14 (14.58) | |
ER, PR, HER2 Status | Negative | N/A | 10 (10.42) |
Tumor Stage | |||
I * | N/A | 7 (7.29) | |
II | N/A | 45 (46.87) | |
III | N/A | 39 (40.63) | |
IV | N/A | 5 (5.21) |
N/A: Not Applicable. * Stage 0 samples (n = 2) were compiled with stage I samples and considered as stage I (n = 5).